openPR Logo
Press release

Investigation announced for Investors in shares of CareDx, Inc (NASDAQ: CDNA)

07-26-2019 07:03 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in CareDx, Inc (NASDAQ: CDNA) shares over potential securities laws violations by CareDx, Inc was

An investigation for investors in CareDx, Inc (NASDAQ: CDNA) shares over potential securities laws violations by CareDx, Inc was

An investigation was announced concerning possible securities laws violations by CareDx, Inc s in connection with certain financial statements.

Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by CareDx, Inc (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Brisbane, CA based CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide.
In 2017, CareDx, Inc launched its AlloSure product for kidney transplant recipients. AlloSure is designed to check for cell-free DNA associated with organ rejection, a serious problem with kidney transplants. AlloSure is currently responsible for 83% of CareDx, Inc's total revenue.

CareDx, Inc reported that its annual Total Revenue rose from $48.32 million in 2017 to $76.56 million in 2018 and that its Net Loss declined from $55.46 million in 2017 to $46.75 million in 2018.

On July 16, 2019, a report noted that the AlloSure test manufactured by CareDx isn't nearly as popular as it seems because it misses around 40% of organ rejections compared to the current standard of care.

Shares of CareDx, Inc (NASDAQ: CDNA) closed on July 25, 2019, at $31.29 per share.

Those who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of CareDx, Inc (NASDAQ: CDNA) here

News-ID: 1812750 • Views: 353

More Releases from Shareholders Foundation

Investigation announced for Investors in Genworth Financial, Inc. (NYSE: GNW)
An investigation was announced concerning potential securities laws violations by Genworth Financial, Inc. in connection with certain financial statements. Investors who purchased shares of Genworth Financial, Inc. (NYSE: GNW), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Genworth Financial, Inc. (NYSE: GNW) concerning whether a
Investigation announced for Long-Term Investors in shares of Dropbox, Inc. (NASD …
An investigation was announced for investors in shares of Dropbox, Inc. (NASDAQ: DBX) concerning potential breaches of fiduciary duties by certain directors of Dropbox, Inc.. Investors who are current long term investors in Dropbox, Inc. (NASDAQ: DBX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: DBX stocks follows
Deadline in Lawsuit for Investors in shares of Trulieve Cannabis Corp. (OTC: TCN …
The Shareholders Foundation announced that a deadline is coming up on February 28, 2020 in the lawsuit filed for certain investors of Trulieve Cannabis Corp. (OTC: TCNN) over alleged securities laws violations by Trulieve Cannabis Corp. Investors who purchased shares of Trulieve Cannabis Corp. (OTC: TCNN) have certain options and there are strict and short deadlines running. Deadline: February 28, 2020. OTC: TCNN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in shares of Canaan Inc. (NASDAQ: CAN)
An investigation was announced concerning potential securities laws violations by Canaan Inc. in connection with certain financial statements. Investors who purchased shares of Canaan Inc. (NASDAQ: CAN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Canaan Inc. (NASDAQ: CAN regarding its business, its prospects and its operations were materially

All 5 Releases


More Releases for CareDx

HLA Typing for Transplant Market 2019-2025| Prominent Players: CareDx, Inc., Bio …
The HLA Typing for Transplant Market is set to exceed USD 0.8 billion by 2025; according to a new research study published by Global Market Insights, Inc. Increasing number of individuals afflicted with terminal and irreversible organ failure is resulting in an increasing demand for organ transplant procedures which will drive industry growth during the forecast years. Elderly population has a higher vulnerability towards various chronic ailments leading to organ
HLA Typing for Transplant Market 2019| Prominent Players: CareDx, Inc., Bio-Rad …
The HLA Typing for Transplant Market is set to exceed USD 0.8 billion by 2025; according to a new research study published by Global Market Insights, Inc. HLA typing for transplant market will witness lucrative growth over the forecast timeframe. Growing demand for solid organ transplants will drive HLA typing for transplant industry growth over the forecast years. These lifesaving transplants are indispensable for treating patients suffering from heart, liver,
Transplantation Diagnostics Market Completive Analysis to 2024:Bio-Rad Laborator …
Research For Market in this report on Global Transplantation Diagnostics Market will keep you apprised in this CAGR growing market by letting you know in-depth how the key players and brands are driving the market in the forecast period of 2019-2025. Further, the markets definition, classifications, applications, and engagements in the Global Transplantation Diagnostics Market have been described. The Global Transplantation Diagnostics Market has been classified according to market size
HLA Typing for Transplant Market Comprehensive Evaluation 2017-2024 with Key Pla …
HLA typing for transplant market is slated to witness lucrative growth over the forecast timeframe. Growing demand for solid organ transplants will drive HLA typing for transplant industry growth over the forecast years. These lifesaving transplants are indispensable for treating patients suffering from heart, liver, lung, kidney disorders as they help to increase patient survival. Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1653 Molecular assays segment is slated to exhibit
Transplant Diagnostics Market 2018 Top Companies Like Thermo Fisher Scientific, …
The key players of the Global Transplant Diagnostics Market are making moves like product launches, joint ventures, developments, merges and accusations which is affecting the Transplant Diagnostics Market and In Vitro Diagnostics Industry as a whole and also affecting the sales, import, export, revenue and CAGR values. We at Data Bridge Market Research take the help of Porter's Five Forces Analysis that explains what the threats of new entrants, threat of
HLA Typing for Transplant Market : 2018 Prominent Players | Pacific Biosciences …
HLA Typing for Transplant Marketto exceed USD 720 million by 2024; according to a new research report. Increasing number of solid organ transplants will fuel industry growth over the forecast timeframe. Growing patient pool suffering from terminal and irreversible organ failure is leading to a surge in solid organ transplant demand. Growing geriatric population will further augment growth as the elderly individuals have a higher susceptibility towards various chronic disorders owing